Risk factors and treatments for brain metastasis in patients with adenocarcinoma of the lung: a retrospective analysis of 373 patients
Abstract Background Risk factors and treatments for brain metastasis (BM) in patients with adenocarcinoma have not been fully profiled in previous studies because of the enrolment of patients with tumours of mixed histology. Thus, we specifically addressed the issue in patients with adenocarcinoma....
Main Authors: | Bo Li, Zhaoxia Dai, Shuai Liu, Xuenan Gu, Yanwei Liu, Xiaoguang Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Chinese Neurosurgical Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41016-018-0113-z |
Similar Items
-
Risk factors of brain metastasis of lung squamous cell carcinoma: a retrospective analysis of 188 patients from single center
by: Bo Li, et al.
Published: (2017-11-01) -
Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
by: Liu J, et al.
Published: (2016-02-01) -
CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma
by: Tong-xu Shen, et al.
Published: (2019-06-01) -
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01) -
Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis
by: Limin CHEN, et al.
Published: (2019-05-01)